VECTUS BIOSYSTEMS LIMITED — Director's Dealing 2022

Oct 3, 2022

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Vectus Biosystems Limited (ASX:VBS) ABN 54 117 526 137

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Maurie Stang
Date of last notice	24 December 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Energy Trading Systems Pty Ltd Maurie Stang is the sole shareholder of the trustee, Energy Trading Systems Pty Ltd, and he is a beneficiary of The MPF Trust. Meditsuper Pty Ltd Maurie Stang is a 50% holder in the trust. Maurie Stang is a 50% shareholder of each of the following companies: Stangcorp Pty Ltd Epitek Corporation Pty Ltd 247 Church Street Pty Ltd Ramlist Pty Ltd Regional Health Care Group Pty Ltd Teknik Pty Ltd
Date of change	28 September 2022

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	2,550,000 fully paid ordinary shares in the name of Energy Trading Systems Pty Ltd 1,500 fully paid ordinary shares in the name of Meditsuper Pty Ltd 1,500 fully paid ordinary shares in the name of Stangcorp Pty Ltd 1,500 fully paid ordinary shares in the name of Epitek Corporation Pty Ltd 1,500 fully paid ordinary shares in the name of 247 Church Street Pty Ltd 1,500 fully paid ordinary shares in the name of Brunswick Property Pty Ltd * 1,500 fully paid ordinary shares in the name of Ramlist Pty Ltd 1,500 fully paid ordinary shares in the name of Regional Health Care Group Pty Ltd 1,500 fully paid ordinary shares in the name of Teknik Pty Ltd 2,000,000 convertible notes, with a 6% interest rate per annum over 36 months, capitalised and paid on the maturity date, being 27 September 2022.
Class	Fully paid ordinary shares
Number acquired	2,285,952 fully paid ordinary shares (being for the conversion of 2,000,000 convertible notes and interest paid as 285,952 shares)
Number disposed	2,000,000 convertible notes converted into shares *1,500 shares in the name of Brunswick Property Pty Ltd sold on 5 January 2021 upon the liquidation of Brunswick Property Pty Ltd
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Conversion of 2,000,000 convertible notes into shares at $0.50 per share and interest paid at 6% per annum over three years as 285,952 shares at $0.668 per share

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change

2,550,000 fully paid ordinary shares in the name of Energy Trading Systems Pty Ltd 2,285,952 fully paid ordinary shares in the name of Maurie Stang 1,500 fully paid ordinary shares in the name of Meditsuper Pty Ltd 1,500 fully paid ordinary shares in the name of Stangcorp Pty Ltd 1,500 fully paid ordinary shares in the name of Epitek Corporation Pty Ltd 1,500 fully paid ordinary shares in the name of 247 Church Street Pty Ltd 1,500 fully paid ordinary shares in the name of Ramlist Pty Ltd 1,500 fully paid ordinary shares in the name of Regional Health Care Group Pty Ltd 1,500 fully paid ordinary shares in the name of Teknik Pty Ltd

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Conversion of convertible notes into fully paid ordinary shares at $0.50 each on maturity date, plus 6% interest rate per annum capitalised and paid on maturity date, being 27 September 2022. The issue of the convertible notes to Maurie Stang was approved by shareholders at the 22 November 2019Annual General Meeting.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	None
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Part 3 – +Closed period

Part 3 – +Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011